Prototype 2.0 in Development – Strategic Update from Allergios
In July 2025, Dr. Holger Engel was appointed as CEO of Allergios to realign the company’s development efforts and prepare the platform for clinical applicability. The objective is clear: develop a robust, automatable version of the GranulEye® prototype to enable functional, cell-based allergy diagnostics in routine clinical settings. Since then, several important steps have been […]